Dr. Magnus Nilsson CEO in Vitrolife

Dr. Magnus Nilsson CEO in Vitrolife The Board of Directors appointed Dr. Magnus Nilsson CEO in Vitrolife AB (publ). Magnus Nilsson was previously Acting CEO in Vitrolife since January 3, 2003. Gothenburg, Sweden, August 13, 2003 The Board of Directors, Vitrolife AB (publ) For further information, please contact; CEO, Dr. Magnus Nilsson Chairman of the Board, Phone: +46 31 721 80 00 Patrik Tigerschiöld Mobile +46 708 22 80 61 Phone: +46 8 614 00 20 Vitrolife is a global biomedical corporation that works with products for cell and tissue technology. The Vitrolife group consists of the parent company, Vitrolife AB (Publ) and four wholly owned subsidiaries: Vitrolife Sweden AB (Gothenburg, Sweden), Vitrolife Inc. (Denver, Colorado), A-Life Ltd. (Edinburgh, Scotland), and A-Life Inc. (Newport Beach, California). The group's operations focused on three geographic areas. · Europe/Middle East · The Americas · Rest of the World Vitrolife's business concept is to develop, produce and sell advanced products and systems for the preparation, cultivation, preservation and support of cells, tissues and organs. ------------------------------------------------------------ This information was brought to you by Waymaker http://www.waymaker.net The following files are available for download: http://www.waymaker.net/bitonline/2003/08/13/20030813BIT00740/wkr0001.doc http://www.waymaker.net/bitonline/2003/08/13/20030813BIT00740/wkr0002.pdf

About Us

Vitrolife is an international medical device Group. Vitrolife develops, produces and markets products for assisted reproduction. Vitrolife has about 400 employees and the company’s products are sold in about 110 markets. The company is headquartered in Gothenburg, Sweden, and there are also offices in Australia, Belgium, China, Denmark, France, Germany, Italy, Japan, United Kingdom and USA. The Vitrolife share is listed on NASDAQ Stockholm.